Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year period

被引:12
作者
Ho, S [1 ]
Teo, P [1 ]
Kwan, WH [1 ]
Choi, P [1 ]
Tjong, J [1 ]
Johnson, PJ [1 ]
机构
[1] Prince Wales Hosp, Dept Clin Oncol, Shatin, Peoples R China
关键词
NPC; staging; IgA VCA titre;
D O I
10.1016/S1368-8375(98)00063-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The distributions of 2093 patients with nasopharyngeal carcinoma (NPC), by stage, over a 12-year-period did not show any evidence of a shift towards early stages despite growing awareness of this prevalent malignancy. The IgA VCA titre was determined for 1880 of these patients. The median titre increased from 40 in stage I to 80 in stages II, III, and IV, before rising to 160 in stage V. The percentage of patients with a titre greater than or equal to 320 increased steadily with advancing stages. Within the same disease stage, the percentage of patients having a particular titre value and the median titre varied considerably from pear to year. Better education of the general population and a better serological marker for screening are needed for the early detection of NPC. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:491 / 495
页数:5
相关论文
共 12 条
[1]   SEROLOGIC DIAGNOSIS OF NASOPHARYNGEAL CARCINOMA - A DOUBLE-BLIND-STUDY OF 4 EB VIRUS-ANTIBODIES WITH EVALUATION BY SEQUENTIAL DISCRIMINATION [J].
CAI, WM ;
LI, YW ;
WU, B ;
LIU, YY ;
HU, YH ;
GU, XZ ;
LIU, HY ;
WANG, GD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (12) :1763-1768
[2]   EPSTEIN-BARR VIRUS-SPECIFIC IGA SERUM ANTIBODIES AS AN OUTSTANDING FEATURE OF NASOPHARYNGEAL CARCINOMA [J].
HENLE, G ;
HENLE, W .
INTERNATIONAL JOURNAL OF CANCER, 1976, 17 (01) :1-7
[3]   NASOPHARYNGEAL CARCINOMA - SIGNIFICANCE OF CHANGES IN EPSTEIN-BARR VIRUS-RELATED ANTIBODY PATTERNS FOLLOWING THERAPY [J].
HENLE, W ;
HO, JHC ;
HENLE, G ;
CHAU, JCW ;
KWAN, HC .
INTERNATIONAL JOURNAL OF CANCER, 1977, 20 (05) :663-672
[4]   EPSTEIN-BARR-VIRUS-SPECIFIC IGA AND IGG SERUM ANTIBODIES IN NASOPHARYNGEAL CARCINOMA [J].
HO, HC ;
NG, MH ;
KWAN, HC ;
CHAU, JCW .
BRITISH JOURNAL OF CANCER, 1976, 34 (06) :655-660
[5]  
HO JHC, 1978, INT J RADIAT ONCOL, V4, P182
[6]  
*HONG KONG HOSP AU, 1993, HONG KONG CANC REG 1
[7]   RETROSPECTIVE ANALYSIS OF 5037 PATIENTS WITH NASOPHARYNGEAL CARCINOMA TREATED DURING 1976-1985 - OVERALL SURVIVAL AND PATTERNS OF FAILURE [J].
LEE, AWM ;
POON, YF ;
FOO, W ;
LAW, SCK ;
CHEUNG, FK ;
CHAN, DKK ;
TUNG, SY ;
THAW, M ;
HO, JHC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (02) :261-270
[8]  
Levine P H, 1981, Cancer Detect Prev, V4, P307
[9]   CHARACTERIZATION OF THE SEROLOGICAL RESPONSE IN MAN TO THE LATENT MEMBRANE-PROTEIN AND THE 6 NUCLEAR ANTIGENS ENCODED BY EPSTEIN-BARR VIRUS [J].
ROWE, M ;
FINKE, J ;
SZIGETI, R ;
KLEIN, G .
JOURNAL OF GENERAL VIROLOGY, 1988, 69 :1217-1228
[10]   NASOPHARYNGEAL CARCINOMA - MODES OF PRESENTATION [J].
SKINNER, DW ;
VANHASSELT, CA ;
TSAO, SY .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1991, 100 (07) :544-551